SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Net sales declined -8.82%  to  Rs. 2730.10 million from Rs. 2994.30 millions.The Net Loss for the quarter ended March 2025 is Rs. -48.80 millions as compared to Net Loss of Rs. -2564.00 millions of corresponding quarter ended March 2024The company reported a good operating profit of 485.40 millions compared to 114.30 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 2730.10 2994.30 -8.82 12837.60 12889.20 -0.40 12837.60 12889.20 -0.40
Other Income 59.50 16.30 265.03 91.40 53.70 70.20 91.40 53.70 70.20
PBIDT 485.40 114.30 324.67 2129.80 -896.90 -337.46 2129.80 -896.90 -337.46
Interest 291.20 306.20 -4.90 1148.10 1059.70 8.34 1148.10 1059.70 8.34
PBDT 194.20 -1425.10 -113.63 981.70 -3853.00 -125.48 981.70 -3853.00 -125.48
Depreciation 243.00 251.00 -3.19 992.50 1030.30 -3.67 992.50 1030.30 -3.67
PBT -48.80 -1676.10 -97.09 -10.80 -4883.30 -99.78 -10.80 -4883.30 -99.78
TAX 0.00 887.90 0.00 0.00 785.40 0.00 0.00 785.40 0.00
Deferred Tax 0.00 887.90 0.00 0.00 785.40 0.00 0.00 785.40 0.00
PAT -48.80 -2564.00 -98.10 -10.80 -5668.70 -99.81 -10.80 -5668.70 -99.81
Equity 402.50 360.00 11.81 402.50 360.00 11.81 402.50 360.00 11.81
PBIDTM(%) 17.78 3.82 365.76 16.59 -6.96 -338.42 16.59 -6.96 -338.42

Solara Active Pharma Share Price

483.05 -10.65 (-2.16%)
16-Apr-2026 13:08 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1678.55
Dr. Reddys Lab 1223.50
Cipla 1230.70
Zydus Lifesciences 936.75
Lupin 2301.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×